...
机译:术前血清TMAO水平是结直肠癌的新预后标志物
Jinzhou Med Univ Affiliated Hosp 1 Dept Oncol Jinzhou 121001 Peoples R China;
Liaohe Oil Field Gen Hosp Dept Oncol Panjin 124000 Peoples R China;
Jinzhou Med Univ Affiliated Hosp 1 Dept Oncol Jinzhou 121001 Peoples R China;
Jinzhou Med Univ Affiliated Hosp 1 Dept Surg Jinzhou 121001 Peoples R China;
Jinzhou Med Univ Affiliated Hosp 1 Dept Oncol Jinzhou 121001 Peoples R China;
Jinzhou Med Univ Affiliated Hosp 1 Dept Surg Jinzhou 121001 Peoples R China;
Jinzhou Med Univ Affiliated Hosp 1 Dept Surg Jinzhou 121001 Peoples R China;
Jinzhou Med Univ Affiliated Hosp 1 Dept Oncol Jinzhou 121001 Peoples R China;
colorectal cancer; disease-free survival; metastasis; prognosis; serum biomarker; TMAO;
机译:术前血清TMAO水平是结直肠癌的新预后标志物
机译:术前血清糖类抗原125水平是结肠直肠癌总体生存的独立阴性预后指标。
机译:术前血管内皮生长因子水平作为II期或III期大肠癌患者的预后指标
机译:原发性乳腺癌患者术前血清CA15-3,CEA和TPS水平的临床和预后意义
机译:端粒DNA含量和hTERTmRNA水平是乳腺癌和前列腺癌的新的预后标志物。
机译:术前血清CEA水平/术前血清CEA水平比值对大肠癌术前血清CEA水平高的患者的预后价值
机译:高术前血清CEa水平的结直肠癌患者预后决定因素的多变量分析:术后血清CEa水平的预后价值